DGAP-News: Novavax to Present at the Wedbush Securities Life Sciences Management Access Conference

 DGAP-News: Novavax to Present at the Wedbush Securities Life Sciences  Management Access Conference  DGAP-News: Novavax, Inc. Novavax to Present at the Wedbush Securities Life Sciences Management Access Conference  07.08.2014 / 22:03  ---------------------------------------------------------------------  GAITHERSBURG, Md., 2014-08-07 22:03 CEST (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, announced today that Barclay 'Buck' Phillips, SVP, Chief Financial Officer and Treasurer, will present at the Wedbush Securities Life Sciences Management Access Conference to be held on Wednesday, August 13, 2014 at 3:40 pm ET in New York City at the Le Parker Meridien hotel.   A live webcast link for the presentation will be available via the company's website at www.novavax.com under Investor Info/Events.   About Novavax  Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage biopharmaceutical company creating vaccines and vaccine adjuvants to address a broad range of infectious diseases worldwide. Using innovative proprietary recombinant nanoparticle vaccine technology, the company produces vaccine candidates to efficiently and effectively respond to both known and newly emergent diseases.             Barclay A. Phillips          SVP, Chief Financial Officer and Treasurer          Novavax, Inc.          240-268-2000 News Source: NASDAQ OMX    ---------------------------------------------------------------------  07.08.2014 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.  The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de  ---------------------------------------------------------------------   Language:    English         Company:     Novavax, Inc.                    United States   ISIN:        US6700021040        End of News    DGAP News-Service   ---------------------------------------------------------------------   281402 07.08.2014                                                        
Press spacebar to pause and continue. Press esc to stop.